Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
Neurodegenerative disorders (NDs) have become a serious health problem worldwide due to the rapid increase in the number of people that are affected and the constantly aging population. Among all NDs, Alzheimer’s and Parkinson’s disease are the most common, and many efforts have been made in the dev...
Main Authors: | Radka Boyuklieva, Bissera Pilicheva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/7/1706 |
Similar Items
-
Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery
by: Radka Boyuklieva, et al.
Published: (2023-05-01) -
Computational, <i>In Vitro,</i> and <i>In Vivo</i> Models for Nose-to-Brain Drug Delivery Studies
by: Radka Boyuklieva, et al.
Published: (2023-08-01) -
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
by: Fabio Sonvico, et al.
Published: (2018-03-01) -
Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery
by: Angeline Shak. Tzeyung, et al.
Published: (2019-01-01) -
Biomaterials for Drugs Nose–Brain Transport: A New Therapeutic Approach for Neurological Diseases
by: Roberta Cassano, et al.
Published: (2021-04-01)